Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-053264
Filing Date
2025-05-28
Accepted
2025-05-28 06:35:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8582
2 EXHIBIT 1 tm2513660d3_ex-1.htm EX-99.1 5985
  Complete submission text file 0001104659-25-053264.txt   16449
Mailing Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200
Business Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200 86-028-64775180
BGM Group Ltd. (Subject) CIK: 0001779578 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0930
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92136 | Film No.: 25991098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ROOM 721, NO.99, JIANGYAN ROAD, HAIZHU GUANGZHOU China NULL
Business Address
Ban Sihai (Filed by) CIK: 0002067090 (see all company filings)

Type: SCHEDULE 13G